INTRODUCTION
============

Huntington's disease (HD) is a monogenetic neurodegenerative disorder associated with characteristic hyperkinetic motoric dysfunction (chorea) accompanied by cognitive and emotional deficits ([@bib17]; [@bib44]; [@bib62]). The disease is of autosomal dominant inheritance and results from an expanded CAG triplet repeat in exon 1 of the gene coding for huntingtin (htt), a 348-kD soluble globular protein. htt's normal function has not yet been identified for certain. It is known to be essential for embryonic development and seems to play important roles in various cellular processes, including vesicular trafficking and coordinating intracellular signaling pathways ([@bib41]; [@bib14]; [@bib15]). The pathology is not simply the consequence of a loss of htt function. Instead, the expanded polyglutamine (poly-Q) tract in the N-terminal region of mutant htt (mhtt) is thought to cause in addition a toxic gain of function ([@bib83]; [@bib49]). Toxicity likely results from aggregated poly-Q--containing proteolytic fragments of mhtt and their interaction with other cellular proteins ([@bib83]; [@bib94]; [@bib115]; [@bib44]). The actual pathomechanism is still unresolved. Particularly sensitive to mhtt are medium spiny neurons in the striatum, but other brain regions and peripheral tissues are also affected ([@bib65]; [@bib88]). Until now, it is unclear why certain cell types are more vulnerable to mhtt-mediated toxicity than others, despite a ubiquitous expression of the htt protein both in the central nervous system and in peripheral tissues ([@bib100]; [@bib95]; [@bib114]; [@bib54]; [@bib88]). The largest tissue outside the central nervous system that shows clear alterations in the disease is skeletal muscle. Weakness and wasting of muscle have been reported both in patients and in animal models of HD ([@bib28]; [@bib40]; [@bib38]; [@bib47]; [@bib117]; [@bib11]). Functional measurements in living muscle fibers are only available for the R6/2 mouse model and demonstrated alterations in membrane properties and excitability ([@bib78]). R6/2 was originally generated by [@bib55] as a transgenic mouse expressing exon 1 of human htt containing a long (144 repeats) expanded glutamine sequence and has since then most frequently been used as a model of early onset HD.

In HD neurons, alterations in Ca^2+^ signaling have been described and suggested to be part of the pathomechanism ([@bib106], [@bib107], [@bib108], [@bib109]; [@bib125]; [@bib5], [@bib6]; [@bib31]; [@bib33]; [@bib42]; [@bib72]). Recently, [@bib19] found that dantrolene, a skeletal muscle relaxant, acts as a neuroprotective agent in a transgenic mouse model of HD (YAC128). Dantrolene decreases excitation-activated Ca^2+^ release from the SR in skeletal muscle ([@bib105]; [@bib48]) and is clinically important because it is the only effective antidote against malignant hyperthermia, a serious hypermetabolic complication in general anesthesia ([@bib82]). Malignant hyperthermia susceptibility generally results from mutations in the RyR1, the predominant Ca^2+^ release channel of the SR. The findings of [@bib19] and [@bib103] suggest that RyRs are involved in the pathomechanism of HD. Because RyR-based Ca^2+^ signaling is central for muscle function ([@bib50]), it may contribute to dysfunctional Ca^2+^ turnover in skeletal muscle pathology in HD. The goal of the present study was to test the hypothesis that the voltage-controlled Ca^2+^ signaling process is changed in skeletal muscle of the R6/2 mouse model of HD.

MATERIALS AND METHODS
=====================

Experimental animals and muscle fiber preparation
-------------------------------------------------

R6/2 mice (B6CBA-Tg (HDexon1)62Gpb/1J x C57BL6J/CBA/caF1; The Jackson Laboratory) and age-matched WT littermates were used for our experiments. The animals were bred in the specific pathogen-free facility of the Animal Research Center of Ulm University. Animal handling was in agreement with the regulations of the local animal welfare committee. Male mice were used at an age of 11--14 wk and killed by CO~2~ application and rapid cervical dislocation. Interosseus muscles were dissected from the hind limb paw in Ringer's solution. Single muscle fibers were enzymatically dissociated in Ringer's solution containing 2 mg/ml collagenase, following published protocols ([@bib52]; [@bib118]).

Experimental setup
------------------

Fluorescence measurements were performed using two different setups equipped with inverted microscopes (Axiovert 100 and 135 TV; Carl Zeiss). For extracellular stimulation experiments, cells were transferred to culture dishes with a coverslip bottom (MatTek Corporation) coated with Matrigel containing DMEM-F12 culture medium and equilibrated with 5% CO~2~ at 37°C. After 30 min and successful fiber attachment, 2 ml of fresh culture medium was added. Fibers were kept in primary culture until measurements were performed (within 2 d after fiber preparation). Fibers were imaged with an oil-immersion objective (40×/1.30; Fluar; Carl Zeiss). Fibers eligible for analysis had to be morphologically intact and adherent to the coverslip, showing cross striation and no "blebbing" or vacuoles. Rectangular current pulses were applied by a digital-to-analogue converter (DigiData 1200; Axon Instruments) interfaced with a custom-built current booster and passed through two stainless steel electrodes immersed in the bath solution. The stimulation electrodes were positioned just outside the field of observation. Pulse duration was 0.5 ms throughout. Fluorescence was excited by a xenon light source (short arc lamp XBO 75W/2 OFR mounted in a lamp housing LH 150 with quartz condenser; Polytec) with stabilized power supply (LPS 200 X; Photo Technology International). Irradiation was controlled with an electromagnetic shutter (Uniblitz VS 25 and Shutter driver D 122; Vincent Associates) and permitted only during the recording interval to minimize photo bleaching. Emitted fluorescence was separated from the exciting light with a dichroic mirror and passed through the emission filter to a photomultiplier (PM; R 268; Hamamatsu Photonics). The recorded field was limited using an adjustable rectangular aperture (View Finder; TILL Photonics). PM signals were filtered with an eight-pole Bessel low pass filter (KF 9006; Zeitz Instrumente). Filtering and signal acquisition varied with the fluorescent probes used in the experiments. Shutter and stimulus control and fluorescence recording were performed with Clampex 8.2 software (Axon Instruments). Bath temperature was recorded with a digital thermometer (Qtemp 600; Merck Eurolab) and maintained between 25 and 26°C during the measurements. For voltage-clamp experiments, bath temperature was 20--23°C, and optical recording procedures differed only in minor details ([@bib118]).

Experimental solutions (concentrations in millimolar)
-----------------------------------------------------

Ringer's solution for extracellular stimulation experiments contained: 145 NaCl, 5 KCl, 3.5 MgCl~2~, 10 HEPES, and 10 glucose, pH 7.4. The external (bathing) solution for voltage-clamp experiments contained: 135 tetraethylammonium hydroxide, 135 HCH~3~SO~3~, 2 MgCl~2~, 10 CaCl~2~, 5 4-aminopyridine, 10 HEPES, 0.001 tetrodotoxin (TTX), 5 glucose, and 0.05 *N*-benzyl-*p*-toluene sulphonamide (BTS), pH 7.4. The internal (pipette) solution for intracellular dialysis contained: 145 CsOH, 135 aspartic acid, 0.75 Na~2~ATP, 4.25 MgATP, 15 EGTA, 1.5 CaCl~2~, 10 HEPES, 0.2 fura-2, and 5 sodium creatine phosphate, pH 7.2.

Action potential (AP) recording
-------------------------------

The potentiometric fluorescent indicator dye di-8-amino-naphthylethenylpyridinium (Di-8-ANEPPS) was used to measure muscle fiber APs. The lipophilic dye accumulates in the sarcolemma and the T-tubular system. The loading protocol was adapted from [@bib74]. Fibers were subjected to 10 µM Di-8-ANEPPS in culture medium for 30 min at 37°C. APs were measured immediately after washing with the experimental Ringer's solution. For fluorescence measurements, we used an excitation filter (BP 470/20), a dichroic beam splitter (FT 493), and an emission filter (BP 505--530; all from Carl Zeiss). The signal from the PM was analogue filtered at 50 kHz and sampled at 100 kHz. A short screening protocol with four sequential pulses of different voltage (+6, −7, +8, and −9 V) was used to check cells in the dish for the presence of APs. The AP threshold was then determined with pairs of rectangular pulses of equal amplitude but opposite polarity spaced 50 ms apart. The amplitude was gradually increased from 1 to 10 V, with a 1-V increment per sweep. The AP trigger voltage was then individually set to a supra-maximal value (1 V above threshold). Pulses were applied at 1 Hz. For analysis, 20 consecutive all-or-none APs were averaged offline and smoothed by cubic spline interpolation. Averaged and smoothed signals were baseline corrected and normalized to the peak of the signal. AP recordings were used for kinetic analysis. A comparison of absolute amplitudes could not be performed because the basal background fluorescence showed considerable fiber-to-fiber variation (probably mainly resulting from dye in the Matrigel coating used for plating the cells).

Ca^2+^ recording in AP-stimulated fibers
----------------------------------------

Cells were loaded with 5 µM fura-2 in its acetomethyl (AM) ester form in Ringer's solution for 45 min. Remaining fura-2-AM was washed out with the experimental solution, and the cells were incubated for 30 min to allow for full intracellular cleavage of the acetoxymethyl ester. 100 µM of the low molecular weight myosin II blocker BTS was added to the Ringer's solution to suppress muscle contraction. During measurements, fluorescence was excited consecutively with UV light at 360 nm (near isosbestic wavelength) and 380 nm (bandwidth of 10 and 15 nm, respectively). Fibers were stimulated during the 380-nm irradiation interval. Filters were obtained from Andover Corporation and Carl Zeiss. The excitation filters were mounted in a custom-built filter changer controlled by the recording software. Fluorescence emission (intensities "F360" and "F380") was recorded at 510 nm. PM signals were analogue filtered at 5 kHz and sampled at 10 kHz. The ratio R = F380/F360 was calculated to normalize for differences in cell diameter and intracellular indicator concentration. In figures, the inverted ratio (-R) is plotted to present rising Ca^2+^ concentrations as upward-going signals. Ratios for Ca^2+^-free (R~min~) and Ca^2+^-saturated (R~max~) conditions were 3.5 and 0.7, respectively, based on calibrations as described previously ([@bib118]).

After screening for Ca^2+^ signals using a four-pulse protocol (see previous paragraph), a double-pulse paradigm (see [Fig. 2 A](#fig2){ref-type="fig"}) was applied to determine the AP threshold. Pulses of equal amplitude but opposite sign, spaced 500 ms apart, were applied. The amplitude was gradually raised from 1 to 10 V, with an increment of 1 V per sweep. The stimulation threshold was defined as the voltage that produced equal all-or-none reactions to both the positive and the negative stimulus. The pulse voltage for further measurements was set to 1 V above excitation threshold, individually for each cell.

Ca^2+^ recording in voltage-clamped fibers
------------------------------------------

Fibers were voltage clamped using a two-electrode system (Axoclamp 2B; Axon Instruments). The experiments were performed in external solution, which was designed to suppress all major ionic currents and enhance the L-type Ca^2+^ current. As described above, fluorescence emission was recorded at 510 nm during 360-nm (isosbestic) and 380-nm excitation. The experimental design, data acquisition, and experimental protocols applied were as described previously ([@bib118]; [@bib1]). R~min~ and R~max~ of fura-2 for this setup were 3.5 and 0.4, respectively. In one series of experiments, using the low affinity indicator fura-FF-AM, both intracellular electrodes were high resistance micropipettes filled with 3 M KCl. In most experiments, only the voltage recording electrode was a sharp KCl-filled micropipette. The current-passing electrode was a micropipette as used in whole-cell patch-clamp studies, which permitted intracellular dialysis with an artificial solution (see above). The high concentration of EGTA in the pipette solution suppressed contraction and generated suitable conditions for the quantification of Ca^2+^ release flux in the muscle fibers ([@bib118]).

Removal model analysis
----------------------

To determine Ca^2+^ removal properties during AP-induced activation, we used a repetitive pulse protocol: A 1-s baseline measurement without stimulation was followed by a single pulse, a silent period of 500 ms, and four consecutive 50-Hz tetani, lasting 120 ms each, separated by 150-ms breaks (see [Fig. 3](#fig3){ref-type="fig"}). This protocol contains five long relaxation intervals at different levels of released Ca^2+^ and therefore intracellular binding site saturation. The relaxation time courses can be used to characterize Ca^2+^ removal ([@bib92]; [@bib118]). Traces were smoothed by averaging six consecutive measurements and applying an adaptive digital filter ([@bib93]). A Ca^2+^ removal model that calculated binding and transport was used to simultaneously fit the time course in the long relaxation intervals. Binding to Ca^2+^-specific (T) sites and Ca^2+^-Mg^2+^ (P) sites of troponin C was calculated as described previously ([@bib79]; [@bib3]). The fixed rate constant values used for the calculations at the given temperature were as follows: for T sites: k~on,T,Ca~ = 115 µM^−1^s^−1^ and k~off,T,Ca~ = 230 s^−1^; for P sites: k~on,P,Ca~ = 300 µM^−1^s^−1^, k~off,P,Ca~ = 0.6 s^−1^, k~on,P,Mg~ = 0.1 µM^−1^s^−1^, and k~off,P,Mg~ = 2 s^−1^. \[T\]~tot~ and \[P\]~tot~, the total concentrations of T and P sites, were 240 µM each. \[Fura\]~tot~ was 100 µM, k~on,Fura~ = 180 µM^−1^s^−1^, and k~off,Fura~ = 50 s^−1^. Fast Ca^2+^ binding to ATP was described by a component proportional to free Ca^2+^ (scaling factor F = 3.6; [@bib3]). In addition, a second saturable (S) and an irreversible nonsaturating binding component (NS) were included in the model to simulate any slow Ca^2+^ removal not described by the slow troponin sites (probably mainly SERCA transport to the SR, but possibly also other protein binding or transport, for instance to mitochondria). These model components were described by total concentration \[S\]~tot~, on- and off-rate constants k~on,S~ and k~off,S~ (for S sites), and rate constant k~NS~ (for the NS component), respectively. These four parameters were adjusted by iteration to minimize the sum of squared deviations between calculated and measured fluorescence ratio in the relaxation phases (see [@bib59], [@bib92], and [Fig. 3](#fig3){ref-type="fig"}).

A similar repetitive pulse protocol (see [Fig. 8](#fig8){ref-type="fig"}) was used in voltage-clamp experiments on fibers dialyzed with high EGTA internal solution. In these experiments, fiber-intrinsic Ca^2+^-binding sites could be neglected in the model simulations. The model components consisted of the indicator dye described by R~min~; R~max~; rate constants k~on,Fura~, k~off,Fura~, and concentration \[Fura\]~total~, of a saturating buffer representing mainly EGTA (parameters k~on,S~, k~off,S~, and \[S\]~total~); and an irreversible uptake mechanism (rate constant k~NS~). \[Fura\]~total~, \[S\]~total~, and K~Fura~ = k~off,Fura~/k~on,Fura~ were set to fixed values of 0.2 mM, 15 mM, and 276 nM, respectively. The parameters k~off,Fura~, k~on,S~, k~off,S~, and k~NS~ were determined by least squares fitting as described above ([@bib118]).

Ca^2+^ release calculation and Ca^2+^ current analysis
------------------------------------------------------

The fluorescence recordings during depolarizing pulses and the best-fit values of kinetic constants in the removal model (see above) were used to calculate the depolarization-induced Ca^2+^ flux into the myoplasmic water space, which is essentially identical to the Ca^2+^ release flux from the SR ([@bib118]). Note that the flux calculation in the voltage-clamp experiments was performed under the assumption of complete intracellular dialysis with the pipette solution. According to a previous estimate ([@bib118]), resulting amplitudes have to be scaled down by a factor of ∼0.4 to take into account the incomplete cellular equilibration within the loading times of our experiments.

L-type Ca^2+^ inward current was measured in parallel with the optical signals and analyzed as described previously ([@bib118]). In brief, the voltage dependence of the leak-corrected inward current density was fitted using the term g~Ca,max~(V − V~Ca~)/(1 + exp((V~1/2~ − V)/k)), where V is the membrane potential; g~Ca,max~ is the maximal Ca^2+^ conductance at large depolarizations, normalized by the linear capacitance; V~Ca~ is the apparent Ca^2+^ reversal potential; V~1/2~ is the voltage of half-maximal activation; and k determines the voltage sensitivity of activation. Similarly, the voltage dependence of the Ca^2+^ input flux (peak and plateau) was fitted by the product of a single Boltzmann function (1/(1 + exp((V~1/2~ − V)/k))) and a linear term (a + bV, with constants a and b).

Protein analysis
----------------

After dissection, interosseus muscles were stored at −80°C in Krebs-Ringer's solution containing 50% glycerol. For myosin heavy chain (MyHC) analysis, muscles were subjected to a protein extraction according to [@bib97]. For myosin light chain (MyLC) analysis, we used the myosin extraction procedure by [@bib104]. Protein concentration was determined using the Bradford method. Separation of proteins by SDS-PAGE was performed using a Mini-Gel system (Bio-Rad Laboratories) with 8 and 12% gels for MyHC and MyLC, respectively. The gels were stained with Roti-Blue (Carl Roth) containing the dye CBBG-250, and stained gels were scanned and analyzed using the software ImageJ (National Institutes of Health).

For quantitative Western blot analysis, muscle lysates were separated by SDS-PAGE and transferred to a PVDF membrane (Bio-Rad Laboratories) by standard procedures. Membranes were blocked in TBS-T (Tris-buffered saline with 0.1% Tween-20) containing 5% (wt/vol) nonfat dry milk for at least 1 h. After blocking, membranes were incubated with the following primary antibodies: myosin fast (1:1,000; M4276; Sigma-Aldrich), mouse anti-MyHC I (1:40; supernatant of mouse hybridoma cell line BA-F8; DSMZ), mouse anti-MyHC IIa (1:20 dilution of supernatant of mouse hybridoma cell line SC-71; DSMZ), anti-MyHC IIb (1:40; isolated from supernatant of mouse hybridoma cell line BF-F3; DSMZ), and rabbit anti-RyR1 polyclonal antibody (1:1,000; AB9078; EMD Millipore). Membranes were incubated at 4°C overnight under slow agitation. Primary antibodies were diluted in blocking solution. After three to five washing steps in TBS, membranes were incubated at room temperature for 1 h with the secondary antibody (goat anti--mouse IgG (H+L)-HPR; 1:2,500; Bio-Rad Laboratories) and Peroxidase-AffiniPure Goat Anti-Rabbit IgG (H+L) (1:10,000; Jackson ImmunoResearch Laboratories, Inc.) and washed again. Bands were visualized (ECL-immunodetection) using ImageQuant LAS 4000 (GE Healthcare). Samples were corrected for background and quantified using ImageQuant LAS 4000 software. All values were normalized to total protein amount of the corresponding lane detected by Pierce Reversible Protein Stain kits (24580; Thermo Fisher Scientific).

Software and statistics
-----------------------

Removal model analysis was performed using software written in Delphi (Borland) and Excel (Microsoft) macro routines ([@bib92]; [@bib118]). Further analysis and statistical calculations were performed using R 2.15 ([@bib75]) running under Ubuntu Linux 12.10. Boxplots in the figures are comprised of median (line), interquartile range (IQR; box), and whiskers extending to the most extreme values within 1.5 times IQR above and below the box boundary. Data in the text are presented as mean value ± SEM (*n* = number of values). Group means were compared by *t* test, Wilcoxon test, and linear mixed effect models, treating genotype as fixed and mouse (individual) as random effect. Differences were considered significant when p-values were \<0.05. Models were fitted with the lmer function provided in the R package lme4, and p-values were estimated by Markov chain Monte Carlo resampling with the pvals.fnc function of the R package languageR. In the figures and tables, significance levels are indicated as follows: \*, P \< 0.05; \*\*, P \< 0.01; and \*\*\*, P \< 0.001.

RESULTS
=======

Optical recording of APs
------------------------

All physiological measurements were performed using enzymatically isolated short muscle fibers of the musculi interossei. R6/2 fibers had a significantly reduced diameter compared with WT: 36.57 ± 0.24 µm (*n* = 1,511) versus 46.32 ± 0.29 µm (*n* = 1,549; P \< 0.01). Fiber length was not significantly different: 518.2 ± 1.8 µm (*n* = 1,549) in WT and 537.2 ± 2.6 µm (*n* = 1,511) in R6/2. However, there was a small group (∼1%) of unusually long fibers (longer than 900 µm) found in R6/2 only.

To determine temporal characteristics of APs triggered by extracellular stimulation, we used the voltage-sensitive fluorescent indicator dye Di-8-ANEPPS. Typical signals (in arbitrary units) are shown in [Fig. 1 (A, B, and E)](#fig1){ref-type="fig"}. The stimulation protocol contained two pulses of equal amplitude but opposite polarity separated by a 50-ms interval ([Fig. 1 A](#fig1){ref-type="fig"}). The recordings consisted of a rapid signal, representing the AP, often followed by a more variable slow transient (see in [Fig. 1 B](#fig1){ref-type="fig"}), presumably resulting from movement. Both signals vanished when applying the sodium channel blocker TTX (100 nM). When screening cells for the presence of regenerative APs, the stimulation voltage was gradually increased using 1-V increments ([Fig. 1 D](#fig1){ref-type="fig"}). In the example shown in [Fig. 1 B](#fig1){ref-type="fig"}, the threshold for excitation was reached at 5 V. The signal showed all-or-none behavior as its super-threshold amplitude was independent of the stimulus size. The fraction of cells responding in this way was lower in R6/2 than in WT, but we did not quantify the difference because of the bias caused by the loss of fibers during isolation and plating. In TTX, only very small and short fluorescence changes persisted increasing in size with stimulation voltage ([Fig. 1 C](#fig1){ref-type="fig"}, rightmost traces). They were the result of local electrotonic responses.

![Fluorometric recording of APs. APs were induced in isolated fibers by extracellular electrical stimulation and recorded with the fluorescent indicator Di-8-ANEPPS. (A) A screening protocol was used containing double pulses of opposite polarity (second row). (B) All-or-none response observed when gradually increasing the pulse voltage in 1-V increments (threshold in this example: 5 V). (C) Same cell and pulse protocol as in B after the addition of 100 nM TTX to the bath solution. (D) Trigger voltages for the recordings in B and C. Recordings in A--C were from WT fibers. (E) Examples of APs (WT and R6/2, normalized) and indication of parameters to quantify kinetic changes: (a) rise time (RT~30--70~) from 30 to 70% of the peak and (b) half-time of decay (t~1/2~). (F) Statistical comparison of RT~30--70~ and t~1/2~ in fibers of WT and R6/2 mice. R6/2 fibers showed a statistically significant increase in both parameters. Data are presented as boxplots showing median (center line), interquartile range (IQR, box), and extreme values within 1.5 times IQR extending from the box limits. \*, P \< 0.05; \*\*\*, P \< 0.001.](JGP_201411255_Fig1){#fig1}

AP timing parameters were compared in 21 R6/2 fibers (five mice) and 39 control fibers (five mice). Representative examples of each genotype and the statistical evaluation of kinetic parameters are shown in [Fig. 1 (E and F](#fig1){ref-type="fig"}, respectively). The rise time of the AP, from 30 to 70% of the peak (RT~30--70~) of the fast fluorescence transient, was significantly longer in R6/2 compared with controls (0.49 vs. 0.29 ms; see [Table 1](#tbl1){ref-type="table"}), as was the half-time of relaxation (1.10 vs. 0.75). These data indicate certain alterations in the excitation properties despite the all-or-none behavior.

AP-induced Ca^2+^ signals
-------------------------

In further experiments, a similar stimulation paradigm was applied to measure intracellular Ca^2+^ signals using the indicator dye fura-2-AM ([Fig. 2 A](#fig2){ref-type="fig"}). Here, the time interval between the two pulses was 500 ms. [Fig. 2 (B and C)](#fig2){ref-type="fig"} shows a representative series of recordings from a WT fiber with increasing pulse amplitude before and after the application of 100 nM TTX, respectively. [Fig. 2 B](#fig2){ref-type="fig"} demonstrates the all-or-none behavior. After the application of TTX, the transients were blocked ([Fig. 2 C](#fig2){ref-type="fig"}). Any remaining small Ca^2+^ release was caused by local depolarizations and showed gradual increase in amplitude with increasing stimulus strength ([Fig. 2 C](#fig2){ref-type="fig"}, rightmost traces).

![Calcium signals induced by APs. (A) Fura-2 calcium transients induced in an interosseus muscle fiber by extracellular electrical stimulation using a double-pulse screening protocol similar to the one in [Fig. 1 A](#fig1){ref-type="fig"}. (B) All-or-none response observed when gradually increasing the pulse voltage in 1-V increments. After reaching a threshold (here, 6 V), cells responded with a uniform signal independently of the applied voltage, resulting from the all-or-none APs. (C) Same cell and pulse protocol as in B after the addition of 100 nM TTX to the bath solution. (D) Trigger voltages for the recordings in B and C. Recordings A--C were from WT fibers. (E) Examples of fura-2 fluorescence ratio signals triggered by single super-threshold pulses in a WT and a R6/2 muscle fiber. The relaxation phases were fitted with double-exponential decay functions (red traces). (F) Statistical evaluation of signal parameters. When compared with WT controls, the R6/2 fibers showed no significant difference in the baseline fluorescence ratio (R) but a significant reduction of the signal peak (-ΔR~peak~). The relaxation time course was slower in R6/2 resulting from a significantly larger value of the smaller time constant (τ~1~) and a larger relative amplitude of the slow phase (A2/(A1 + A2)). The time constant of the slow relaxation phase (τ~2~) was not significantly changed. Note that this and the subsequent figures show inverted plots of the ratio signals because the fluorescence measured at 380-nm excitation decreases when the Ca^2+^ concentration rises (see Materials and methods). Data are presented as boxplots showing median (center line), interquartile range (IQR, box), and extreme values within 1.5 times IQR extending from the box limits. \*\*\*, P \< 0.001.](JGP_201411255_Fig2){#fig2}

Representative Ca^2+^ transients of each genotype and the evaluation of their properties are shown in [Fig. 2 (E and F](#fig2){ref-type="fig"}, respectively). The AP-induced fluorescence ratio signals obtained from 101 fibers of seven R6/2 mice showed a 20% smaller mean amplitude (-ΔR~peak~) at the first pulse compared with controls (138 fibers of eight mice; see [Table 1](#tbl1){ref-type="table"}). The difference was statistically significant (P \< 0.001). In contrast, the mean values of the resting ratios (R) determined in a 300-ms interval of the baseline before the first stimulus were not significantly different ([Table 1](#tbl1){ref-type="table"}).

###### 

Parameters determined in AP stimulation experiments

  Parameter               WT                     R6/2            Significance
  ----------------------- ---------------------- --------------- --------------
                          APs                                    
  RT~30--70~ (ms)         0.286 ± 0.022          0.49 ± 0.049    \*\*\*
  t~peak~ (ms)            1.183 ± 0.045          1.678 ± 0.091   \*\*\*
  t~1/2~ (ms)             0.745 ± 0.022          1.10 ± 0.112    \*
                          Calcium signals                        
  R                       2.95 ± 0.008           2.938 ± 0.013   
  -ΔR~peak~               1.711 ± 0.016          1.376 ± 0.022   \*\*\*
  τ~1~ (ms)               29.69 ± 0.49           38.66 ± 0.98    \*\*\*
  τ~2~ (ms)               512 ± 11.0             544 ± 16.9      
  A~2~/(A~1~ + A~2~)      0.111 ± 0.003          0.144 ± 0.005   \*\*\*
                          Calcium removal                        
  *S*~tot~ (mM)           2.16 ± 0.077           2.06 ± 0.601    
  k~on,S~ (µM^−1^s^−1^)   5.12 ± 0.118           11.0 ± 3.10     
  k~off,S~ (s^−1^)        0.733 ± 0.017          1.64 ± 0.67     
  k~NS~ (s^−1^)           9,620 ± 282            4,860 ± 216     \*\*\*
                          Calcium release flux                   
  Amplitude (Ms^−1^)      0.207 ± 0.006          0.081 ± 0.003   \*\*\*
  t~peak~ (ms)            1.98 ± 0.041           2.75 ± 0.078    \*\*\*

Parameters obtained from recordings of APs and Ca^2+^ transients elicited by extracellular stimulation. See Materials and methods and Results for definitions. Numbers of experiments (WT vs. R6/2) were 39 versus 21 for AP recordings, 138 versus 101 for Ca^2+^ transients, and 116 versus 64 for Ca^2+^ removal and Ca^2+^ release flux determination. \*, P \< 0.05; \*\*\*, P \< 0.001.

We also compared the kinetic properties of the intracellular Ca^2+^ signals by determining the time to the peak (t~peak~) and by fitting dual-exponential functions to the decay after the peak (indicated by red lines in [Fig. 2 E](#fig2){ref-type="fig"}). The data show that the decay is slower in R6/2 fibers, resulting from increases in both the time constant τ~1~ of the fast exponential and the relative contribution of the slow exponential component A~2~ to the total amplitude ([Fig. 2 F](#fig2){ref-type="fig"}). The means of both increased by 30% ([Table 1](#tbl1){ref-type="table"}). The larger time constant τ~2~ was unaffected. Further, we checked whether the increased time constant τ~1~ was correlated with the decrease in calcium transient amplitude. In WT fibers, there was only a weak correlation (correlation coefficient r = −0.325 and P = 0.0003). R6/2 fibers showed a clearer correlation (r = −0.717 and P \< 0.0001). A possible interpretation is that a common underlying mechanism is affecting both Ca^2+^ release and removal (see Discussion), and that R6/2 muscle contains a broad spectrum of differently affected fibers (from strongly altered to almost normal).

Removal model analysis of AP-induced Ca^2+^ signals
---------------------------------------------------

To obtain more specific information about functional changes underlying the altered amplitude and time course, we used a model that simulates the distribution of released calcium to various Ca^2+^ removal components and fitted it to measured fluorescence signals, as originally described by [@bib59] (see also Materials and methods). To apply the removal model, isolated fibers were subjected to a paradigm ([Fig. 3 C](#fig3){ref-type="fig"}) in which a single AP was followed by four sequential trains of APs at a stimulation frequency of 50 Hz (for a similar approach see also [@bib74]). The first train started 500 ms after the leading pulse, and each pulse sequence was separated from the next by a 150-ms interval.

![Removal model analysis and Ca^2+^ release flux determination. (A) A Ca^2+^ binding and transport model simulating the time course of Ca^2+^ distribution to different cellular components (see Materials and methods) was fitted simultaneously to the five long relaxation phases of fura-2 fluorescence ratio transients, which were triggered by repetitive pulsing. Red traces show the best fit to the data of the model-generated functions. (B) Ca^2+^ release flux, calculated using the best-fit model parameters. A substantial reduction of flux amplitude was found in R6/2 fibers compared with WT controls. (C) Stimulation protocol consisting of a single pulse and four 50-Hz pulse episodes.](JGP_201411255_Fig3){#fig3}

The analysis procedure provides a simultaneous best fit to all long relaxation phases of the fluorescence ratio signals by optimizing a subset of the model parameters (see Materials and methods). The model consisted of fixed components describing the binding of Ca^2+^ to the indicator dye, to troponin C, and to ATP ([@bib79]; [@bib3]). Any residual deviation from the measured relaxation time course not described by the fixed model components was minimized by adjusting two further slow Ca^2+^ removal components: (1) a nonsaturable component (NS) exhibiting a rate proportional to free Ca^2+^ concentration, and (2) a saturable component (S) providing a second slow reversible binding compartment in addition to the Ca^2+^-Mg^2+^ sites of troponin C. Free parameters in the model that were determined by least-squares fitting were the three rate constants (k~NS~, k~on,S~, and k~off,S~) and the concentration of the saturable sites (S~tot~). As shown in the representative examples of [Fig. 3 A](#fig3){ref-type="fig"}, the Ca^2+^ removal model provided decent fits, i.e., described well the time course of the relaxation phases both in WT and in R6/2 fibers.

[Fig. 3 A](#fig3){ref-type="fig"} demonstrates changes in the time course of the Ca^2+^ transients. A slowing in the calcium transient of the R6/2 fiber is obvious, visible in particular at the end of the last pulse train. The consequence of the slower kinetics in R6/2 fibers is a staircase-like buildup of amplitudes during the tetani that is not so evident in the WT. Consistent with the changes in the fluorescence ratio amplitude in the previously described set of measurements ([Fig. 2 F](#fig2){ref-type="fig"}), the calculated peak free Ca^2+^ concentration (after kinetic deconvolution by the model) was significantly smaller (factor 0.45). The values were 4.64 ± 0.134 µM for WT and 2.09 ± 0.065 µM for R6/2 (P \< 0.001). The baseline free Ca^2+^ concentration was not significantly different (66.97 ± 1.19 nM for WT and 74.96 ± 2.86 nM for R6/2; P = 0.192). The mean values of the free removal parameters *S*~tot~, *k*~on,S~, *k*~off,S~, and *k*~NS~ are listed in [Table 1](#tbl1){ref-type="table"}. Of the four parameters, *k~NS~* was the only one that differed significantly (decrease to 50% of the WT value). It determines the final removal of Ca^2+^ from the cytoplasmic binding sites and seems to be the main determinant of the slower relaxation time course in R6/2 fibers.

[Fig. 4](#fig4){ref-type="fig"} illustrates the consequences of the observed changes for overall slow removal calculated as the total amount of Ca^2+^ bound and transported by the following components: P sites of TnC, NS, and S (for definition see Materials and methods). A single fluorescence transient (arbitrarily chosen as the average of all WT measurements) was used as input, and the calculation was performed by applying all WT ([Fig. 4](#fig4){ref-type="fig"}, left) and R6/2 (right) removal parameters, respectively. It is evident that the overall clearance efficiency is greatly reduced in R6/2 fibers (red trace) compared with WT fibers (black trace). The Ca^2+^ in the three slow compartments, 500 ms after a single AP, was 57% of the WT value. 500 ms after the last tetanus, it was 52% of the corresponding WT value.

![Lower efficiency of Ca^2+^ removal in R6/2 muscle fibers. (A) Mean WT fluorescence ratio signal (average of 120 WT measurements obtained with the protocol of [Fig. 3](#fig3){ref-type="fig"}). (B) This trace was used as a standard input signal to calculate the occupancy of the slow removal components of the model for all best-fit parameter sets obtained in the removal analysis of WT (black trace) and R6/2 measurements (red trace). The result shows a highly significant decrease in overall slow removal activity for R6/2 muscle fibers. Dashed lines indicate SEM.](JGP_201411255_Fig4){#fig4}

AP-induced Ca^2+^ release flux
------------------------------

The result of the model analysis not only provides information on Ca^2+^ removal properties, but it also leads to an estimate of the underlying Ca^2+^ release flux from the SR ([@bib60]; [@bib118]) caused by the APs. The calculated Ca^2+^ release flux derived from the fluorescence ratio traces of [Fig. 3 A](#fig3){ref-type="fig"} is shown in [Fig. 3 B](#fig3){ref-type="fig"}. On average, R6/2 fibers exhibited a considerably smaller release flux amplitude. The mean amplitude (peak Ca^2+^ release flux) for the initial single pulse was reduced to 39% ([Fig. 5 A](#fig5){ref-type="fig"}, left, and [Table 1](#tbl1){ref-type="table"}).

![Characteristics of AP-triggered Ca^2+^ release flux in WT and R6/2 fibers. (A) Peak calcium release flux was significantly reduced in R6/2 (left). The time-to-peak for release flux was delayed by ∼1 ms (right), paralleling a similar change in the time-to-peak of the AP (middle). (B; left) The progressive decrease of peak Ca^2+^ release flux during repetitive excitation (a) was analyzed by fitting a single-exponential decay function to the peak values of the first tetanus in the sequence. Recovery within the 150-ms interval in between tetani (b) was quantified by determining the last peak of the first tetanus (A~1,last~) as a fraction of the first peak of the second tetanus (A~2,first~). (Right) During the tetanus, peak Ca^2+^ release flux decreased to a lower end level in R6/2 (red trace) compared with WT fibers (black trace). (C) Statistical evaluation of decay and recovery. Fractional decrease was 0.566 ± 0.009 (*n* = 116) in WT compared with 0.397 ± 0.011 (*n* = 64) in R6/2 (\*\*\*, P \< 0.001). The time constant of the decline (middle) was not significantly different: 21 ± 1 ms in WT and 24 ± 1 ms in R6/2 (P = 0.121). Recovery within 150 ms was larger in R6/2 fibers, corresponding to a lower A~1,last~/A~2,first~ ratio (right): The mean ratio was 0.704 ± 0.011 in WT and 0.5 ± 0.011 in R6/2 (\*\*\*, P \< 0.001). Data in B are means ± SEM. For explanation of boxplots in A and B, see Materials and methods.](JGP_201411255_Fig5){#fig5}

When analyzing further the time course of the calculated spike-like Ca^2+^ release flux, an increase in t~peak~ from 1.98 ms in WT to 2.75 ms in R6/2 was noticed ([Fig. 5 A](#fig5){ref-type="fig"}, right, [Table 1](#tbl1){ref-type="table"}). This change likely results from a corresponding change in the t~peak~ values of the APs ([Fig. 5 A](#fig5){ref-type="fig"}, middle), whose means increased from 1.18 to 1.68 ms ([Table 1](#tbl1){ref-type="table"}). The delay between AP peak and Ca^2+^ release peak can be explained by the time required for the voltage sensing by the dihydropyridine receptors (DHPRs) and the gating of the RyRs.

Within each of the four consecutive 120-ms lasting trains of stimuli (elicited at a frequency of 50 Hz), the peak Ca^2+^ release flux rapidly declined to an approximately steady level ([Fig. 3 B](#fig3){ref-type="fig"}). The decline likely results from both Ca^2+^ depletion in the SR and Ca^2+^-dependent inactivation of the RyRs. The relative degree of Ca^2+^ release flux inhibition was significantly higher in R6/2 fibers, as shown in [Fig. 5 (B and C)](#fig5){ref-type="fig"}. The mean steady level (relative to the initial peak) obtained from single-exponential least-square fits was 70% of the WT value ([Fig. 5 C](#fig5){ref-type="fig"}, left) with little change in the mean time constant of decay ([Fig. 5 C](#fig5){ref-type="fig"}, middle). The fractional recovery in the 150-ms intervals between tetani was larger in R6/2 compared with WT ([Fig. 5 C](#fig5){ref-type="fig"}, right). As a consequence, the fractional decrease of the initial peaks within the series of four tetani was not different.

Voltage clamp--induced Ca^2+^ signals
-------------------------------------

The AP-stimulated Ca^2+^ signals indicated a significant decrease in both Ca^2+^ removal activity and Ca^2+^ release flux from the SR. Because changes in APs were also detected, the specific aim of the following experiments was to determine whether the differences between R6/2 and WT muscle fibers were independent of any differences in membrane voltage. For this purpose, we controlled the muscle fiber membrane potential using a two-electrode voltage-clamp technique and studied Ca^2+^ signals elicited by voltage steps from preset holding potentials. In a first series of voltage-clamp experiments, we used sharp microelectrodes to minimize changes in the physiological properties of the intracellular space. Again, we applied the indicator dye in its AM ester form from the extracellular space. The extracellular solution was designed to block excessive ionic currents to avoid space-clamp problems. The high affinity indicator fura-2 was chosen in the previous experiments because resting calcium and the small slow component of relaxation could be well resolved. A drawback is its nonlinearity and the necessity of a kinetic deconvolution of the ratio signals in the model analysis. Therefore, we also tried the lower affinity ratiometric Ca^2+^ indicator fura-FF ([@bib118]). However, because of the lower signal-to-noise ratio, we could not reliably evaluate removal and release kinetics by fitting model-generated curves to the individual recordings. To detect possible changes in Ca^2+^ release and removal rate in fura-FF experiments, we evaluated the maxima and minima of the time derivative during the rising and falling phase of the Ca^2+^ transients, respectively.

[Fig. 6](#fig6){ref-type="fig"} shows results obtained with a repetitive activation protocol similar to the one used in [Fig. 3](#fig3){ref-type="fig"}: a sequence of four 50-ms voltage steps to 0 mV was applied, separated by intervals of 150 ms. The figure shows the mean fluorescence ratio signal ([Fig. 6 A](#fig6){ref-type="fig"}) and the corresponding mean time derivative ([Fig. 6 B](#fig6){ref-type="fig"}) obtained from 18 WT fibers and 11 R6/2 fibers (five and six mice, respectively). Both the peak rate of rise at the onset of the pulse and the peak rate of decrease at the end of the pulse were significantly smaller in the R6/2 group ([Fig. 6 C](#fig6){ref-type="fig"}). Moreover, the R6/2 group contained three fibers (not included in the analysis of [Fig. 6 C](#fig6){ref-type="fig"}), which differed from the rest of the cells by their much slower decay time course. No fiber with comparable characteristics was found among the WT group in this series of measurements. Therefore, consistent with the results from AP-triggered Ca^2+^ signals, these findings in voltage-clamped fibers likewise point to reduced effectiveness in removing released Ca^2+^ from the cytoplasmic space and to a considerable decrease in Ca^2+^ release flux.

![Evidence for reduced Ca^2+^ release and removal rates in voltage-clamped R6/2 muscle fibers. (A) Mean fura-FF fluorescence ratio signals during stimulation by four sequential 50-ms pulses to 0 mV in WT and R6/2 (18 and 11 fibers, respectively). (B) Mean time derivatives of the same sets of fibers. (C) Comparison of the maximal rates of rise (left) and decay (right) of the signals. Both mean on- and off-rates were significantly smaller in R6/2 fibers, suggesting reduced Ca^2+^ release and removal rates. Data are presented as boxplots showing median (center line), interquartile range (IQR, box), and extreme values within 1.5 times IQR extending from the box limits. \*, P \< 0.05; \*\*\*, P \< 0.001.](JGP_201411255_Fig6){#fig6}

Ca^2+^ release determination in voltage-clamped muscle fibers
-------------------------------------------------------------

Next, we used a method that facilitates the calculation of Ca^2+^ release flux in voltage-clamped fibers. In these experiments, the current-passing electrode was exchanged for a patch pipette--like low resistance microelectrode that allowed us to dialyze the intracellular space with an isosmolar artificial solution. The pipette solution contained a high concentration (15 mM) of EGTA and fura-2 (200 µM). These conditions simplify the model description of cytoplasmic Ca^2+^ binding because released Ca^2+^ is predominantly bound to EGTA ([@bib39]; [@bib93]; [@bib92]; [@bib118]). In addition, the artificial internal solution prevents movement, buffers intracellular ATP, and contains Cs^+^ to eliminate residual K^+^ outward currents. This permitted the recording of L-type Ca^2+^ currents originating from the DHPR (Ca~V~1.1) in parallel to the Ca^2+^ transients, which we found not feasible in nondialyzed fibers because of substantial ionic current contamination. [Fig. 7](#fig7){ref-type="fig"} shows examples of recordings of simultaneously measured Ca^2+^ currents (C and E) and Ca^2+^ transients (B and D) for different step voltages between −40 and +50 mV. The time course of the Ca^2+^ transients is determined by the strong EGTA buffering and the kinetics of fura-2 ([@bib101]). At pulse off, an elevated, very slowly decaying component (truncated in [Fig. 7](#fig7){ref-type="fig"}) is discernable, resulting from the dissociation of Ca^2+^ that was bound to EGTA during the pulse and the slow rate of Ca^2+^ return to the SR.

![Activation of L-type Ca^2+^ currents and fluorometric Ca^2+^ transients by step depolarizations to different voltages in dialyzed muscle fibers. (A) Rectangular voltage pulses of 100-ms duration and different amplitude. (B and D) Changes in fura-2 fluorescence ratio R in muscle fibers of a WT and a R6/2 mouse, respectively. (C and E) L-type Ca^2+^ currents recorded simultaneously in the same fibers. Note that the rapid phases at the beginning and end of the recordings are partly truncated. Linear capacitance values of the two fibers were 4.60 nF for WT and 2.17 nF for R6/2.](JGP_201411255_Fig7){#fig7}

To determine the time course of the Ca^2+^ release flux in these experiments, we performed a removal model fit comparable to that used in the analysis of AP-triggered Ca^2+^ signals. The procedure profits from the fact that the high intracellular EGTA is the dominating Ca^2+^ buffer in the cytoplasm (for details see [@bib93], [@bib92], and [@bib118]). Representative examples of the model fit (red traces) to fura-2 ratio signals and the calculated Ca^2+^ release flux are shown in [Fig. 8 (A and B](#fig8){ref-type="fig"}, respectively).

![Model fit to determine Ca^2+^ removal and Ca^2+^ release. (A) Representative fura-2 fluorescence ratio traces obtained during repetitive pulse activation in a WT and a R6/2 muscle fiber. The kinetic model described in Materials and methods with free parameters k~off,Fura~, k~on,S~, k~off,S~, and k~NS~ was used to generate the curves highlighted in red and to fit them to the measured data. Mean best-fit parameter values are listed in [Table 2](#tbl2){ref-type="table"}. (B) Ca^2+^ release flux calculated using the best-fit parameters of A. (C) Changes in membrane voltage that elicited the signals in A.](JGP_201411255_Fig8){#fig8}

Voltage dependence of Ca^2+^ entry and release gating
-----------------------------------------------------

[Fig. 9](#fig9){ref-type="fig"} presents analysis results for the voltage-dependent activation of both Ca^2+^ current and Ca^2+^ signals. [Fig. 9 A](#fig9){ref-type="fig"} indicates two differences in the L-type Ca^2+^ current of R6/2 fibers: a decrease in maximal amplitude and a lower threshold for activation. [Fig. 9 B](#fig9){ref-type="fig"} demonstrates the threshold change in the voltage gating of the channels: Plotting the fractional activation of normalized L-type conductance as a function of the membrane potential shows a significant shift of ∼7 mV to more negative membrane potentials in the R6/2 fibers. The absolute value of maximal conductance per fiber capacitance was decreased by 35% from 180 S/F in WT to 117 S/F in R6/2 ([Table 2](#tbl2){ref-type="table"}). The decrease in L-type channel conductance was accompanied by a similar (30%) decrease in the amplitude of the fluorescence ratio signal at maximal activation and a lower threshold of voltage-dependent Ca^2+^ release activation. V~1/2~ differed by 8 mV. The plots of [Fig. 9 (C and D)](#fig9){ref-type="fig"} demonstrate the voltage threshold change in R6/2 fibers for the peak and the plateau phase of the Ca^2+^ release flux, respectively. In another series of experiments with nondialyzed fibers, in which Ca^2+^ current data were not available, amplitude was likewise reduced, but no significant voltage shift could be noticed.

![Voltage dependence of Ca^2+^ entry and release signals in muscle fibers from WT and R6/2 mice. (A) Voltage dependence of L-type Ca^2+^ current density. (B) Normalized Ca^2+^ conductance derived from the data shown in A. Black symbols and lines (*n* = 17), WT; red symbols and lines (*n* = 9), R6/2. (C) Normalized peak Ca^2+^ release flux. (D) Normalized plateau of Ca^2+^ release flux, determined as the average of the values between 25 and 75 ms after pulse-on. Values from the different experiments were averaged after normalization to the maximum (WT, *n* = 19; R6/2, *n* = 10). (E) Representative Ca^2+^ release flux traces at different pulse voltages of a WT and a R6/2 fiber. (F) Peak SR Ca^2+^ permeability (in s^−1^, corresponding to 0.1%/ms) derived from the Ca^2+^ release flux traces evaluated in C and D. For parameter comparison, see [Table 2](#tbl2){ref-type="table"}. The curves were generated using the parameter mean values. Data are means ± SEM.](JGP_201411255_Fig9){#fig9}

###### 

Parameters determined in voltage-clamp experiments

  Parameter               WT                                        R6/2            Significance
  ----------------------- ----------------------------------------- --------------- --------------
                          **L-type calcium current**                                
                          Activation                                                
  V~1/2~ (mV)             0.40 ± 0.56                               −6.20 ± 1.14    \*\*\*
  k (mV)                  5.05 ± 0.18                               6.68 ± 0.46     \*\*\*
  g~max~ (SF^−1^)         180 ± 9.06                                117 ± 10.59     \*\*\*
  V~rev~ (mV)             69.21 ± 2.38                              77.33 ± 5.83    
  C~m~ (nF)               5.26 ± 0.40                               3.64 ± 0.48     \*
                          Availability                                              
  V~1/2~ (mV)             −31.03 ± 1.24                             −30.20 ± 1.43   
  k (mV)                  8.32 ± 0.42                               9.32 ± 0.50     
                          **Calcium removal**                                       
  k~off,Fura~ (s^−1^)     39.90 ± 2.48                              40.73 ± 3.89    
  k~on,S~ (µM^−1^s^−1^)   26.71 ± 3.62                              48.41 ± 16.81   
  k~off,S~ (s^−1^)        6.11 ± 0.76                               5.11 ± 1.01     
  k~NS~ (s^−1^)           7,743 ± 1,256                             8,114 ± 2,718   
                          **Calcium release flux (peak)**                           
                          Activation                                                
  V~1/2~ (mV)             −10.81 ± 1.43                             −18.71 ± 0.80   \*\*\*
  k (mV)                  7.29 ± 0.39                               7.76 ± 0.33     
  a (Ms^−1^V^−1^)         1.11 ± 0.43                               0.53 ± 0.15     
  b (Ms^−1^)              0.245 ± 0.034                             0.092 ± 0.017   \*\*\*
  Max (Ms^−1^)            0.293 ± 0.047                             0.119 ± 0.021   \*\*
                          Availability                                              
  V~1/2~ (mV)             −37.95 ± 0.10                             −42.51 ± 1.18   \*
  k (mV)                  5.68 ± 0.42                               4.89 ± 0.26     
                          **Calcium release permeability (peak)**                   
                          Activation                                                
  V~1/2~ (mV)             −5.81 ± 1.99                              −15.82 ± 2.31   \*\*
  k (mV)                  8.08 ± 0.48                               9.10 ± 0.79     
  a (s^−1^mV^−1^)         0.077 ± 0.095                             0.169 ± 0.033   
  b (s^−1^)               57.37 ± 5.94                              26.97 ± 1.42    \*\*\*
  Max (s^−1^)             60.92 ± 6.06                              35.90 ± 1.83    \*\*\*

Best-fit parameters describing voltage dependence of activation and steady-state availability of L-type Ca^2+^ current and Ca^2+^ release and of the removal model used for calculating Ca^2+^ release flux. Numbers of experiments (WT vs. R6/2) were 17 versus 9 for L-type Ca^2+^ current activation and 20 versus 11 for availability, 19 versus 10 for Ca^2+^ removal fit and Ca^2+^ release activation, and 18 versus 11 for Ca^2+^ release availability. V~rev~, reversal potential; C~m~, linear capacitance; Max, maximal value at +50 mV. For definitions of the other parameters, see Materials and methods. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001.

Qualitatively, the phasic time course of the traces ([Figs. 8 B](#fig8){ref-type="fig"} and [9 E](#fig9){ref-type="fig"}) resembles the response to repetitive stimulation by APs ([Fig. 3 B](#fig3){ref-type="fig"}). However, the fractional decline in flux amplitude was generally smaller during a spike sequence compared with equally long voltage steps, possibly caused by the lower effective depolarization and lower fractional SR depletion during a series of short spikes. It is generally assumed that the rapid decline after the peak results from both inactivation of RyRs and SR depletion, whereas the subsequent slow decline reflects mainly depletion during a residual steady RyR activity. Using this assumption, we subjected the Ca^2+^ release flux traces to a correction for the putative depletion effect to derive an estimate of the voltage-activated changes in SR Ca^2+^ permeability ([@bib91]; [@bib39]). The voltage dependence of peak permeability is shown in [Fig. 9 F](#fig9){ref-type="fig"} (parameters are listed in [Table 2](#tbl2){ref-type="table"}). The amplitude at maximal depolarization to +50 mV (Max) decreased to 59% of the WT value ([Table 2](#tbl2){ref-type="table"}). This procedure also provides an estimate of the initial Ca^2+^ content of the release compartment (concentration relative to myoplasmic water space). The values (in millimolar for the +50-mV steps) were 5.14 ± 0.61 for WT and 3.40 ± 0.51 for R6/2 (P \< 0.05), assuming full loading of the cell with the pipette solution. Using the approximate estimate of 0.4 of mean fractional fiber dialysis at the time of the measurements ([@bib118]), the estimated values are 2.06 and 1.36 mM, respectively.

Both L-type Ca^2+^ current and Ca^2+^ release flux exhibit a slow voltage-dependent inactivation when depolarization is maintained over seconds (for references see [@bib58]). We performed further experiments to investigate whether a change in steady-state inactivation might have caused the decrease in maximal Ca^2+^ signal activation. We applied an inactivation protocol using progressively decreasing levels of polarization (for intervals of 30 s each), followed by a test step of 100 ms to +20 mV. The response to the test pulse decreases with conditioning voltage ([Fig. 10](#fig10){ref-type="fig"}). Fits of the voltage dependence using canonical Boltzmann functions showed no significant differences for Ca^2+^ current, but a shift in V~1/2~ to the left by 4.6 mV for Ca^2+^ release ([Table 2](#tbl2){ref-type="table"}). This relatively small change could hardly explain the dramatic decrease in SR Ca^2+^ permeability shown in [Fig. 9 F](#fig9){ref-type="fig"} and might be a consequence of the shift in activation resulting in a change in the voltage dependence of steady-state SR depletion (see [@bib58], and [@bib80]). The insets show estimates of the relative size of steady-state Ca^2+^ current ([Fig. 10 A](#fig10){ref-type="fig"}) and Ca^2+^ permeability ([Fig. 10 B](#fig10){ref-type="fig"}) for the same range of potentials determined by combining the voltage dependence of availability and activation (see [Fig. 10](#fig10){ref-type="fig"} legend and Discussion).

![Voltage-dependent availability of Ca^2+^ current and Ca^2+^ release. (A) Fractional availability of L-type Ca^2+^ current in WT (black; *n* = 20) and R6/2 (red; *n* = 11) muscle fibers. Data of each fiber were fitted by canonical Boltzmann functions. (B) Fractional availability of peak Ca^2+^ flux in WT (*n* = 18) and R6/2 (*n* = 11) muscle fibers. For the best-fit parameters, see [Table 2](#tbl2){ref-type="table"}. The curves were constructed using the mean values of V~1/2~ and k (see [Table 2](#tbl2){ref-type="table"}). The insets show relative steady-state window current and window permeability calculated by multiplying each voltage dependence of availability by the voltage dependence of inward current ([Fig. 9 A](#fig9){ref-type="fig"}) and permeability (plateau after the peak), respectively. The maximum values for R6/2 (red traces) were used for normalizing the window curves. These values were 0.384 A/F (current) and 0.183 s^−1^ (permeability), respectively. Data are means ± SEM.](JGP_201411255_Fig10){#fig10}

Myosin isotype determination and RyR1 quantification
----------------------------------------------------

Previous results on human HD and mouse R6/2 muscle showing changes in the mRNA expression patterns ([@bib99]) and fiber histology ([@bib78]) suggested a transition to slower fiber-type characteristics. It has been reported that slow fibers of the mouse soleus muscle release Ca^2+^ at a much lower rate per AP than fast fibers of the extensor digitorum longus muscle ([@bib3], [@bib4]). Therefore, it could be suspected that the functional changes observed by us result from a fast to slow transition in fiber type. A frequently used method to distinguish slow (type I) from fast (type II) muscle is determining the various myosin isoforms ([@bib73]; [@bib98]; [@bib112]; [@bib34]; [@bib90]). To test whether changes in myosin isoforms are detectable in R6/2 interosseus muscles, we performed SDS gel electrophoresis of muscle extracts using published protocols ([@bib104]; [@bib97]). Both MyHCs and MyLCs were separated using gels of different density (see [Fig. 11, A--C](#fig11){ref-type="fig"}, and Materials and methods). As reported previously by [@bib34], the interosseus is a type IIA muscle (fast, oxidative). In our electrophoresis experiments, we confirmed this finding ([Fig. 11, A--C](#fig11){ref-type="fig"}), but we also noticed a small band of type I (∼10%) and traces of type IIx MyHCs (\<1%). Comparing the relative amounts of I and IIa heavy chains in WT and R6/2 muscles showed no significant alteration ([Fig. 11 C](#fig11){ref-type="fig"}, left). Changes, even if only small, were confined to the light chain pattern ([Fig. 11 C](#fig11){ref-type="fig"}, right). These results rule out that our functional observations originate from fiber-type transformations.

![Quantification of myosin and RyR1. (A--C) SDS gel electrophoretic separation of MyHCs and MyLCs and (D and E) quantitative Western blot analysis of RyR1. (A) Representative gels (WT) stained with Roti-Blue. Different concentrations of protein were loaded on 8% (MyHC) and 12% (MyLC) gels. (B) Mean fractional contributions of the different isoforms (left, MyHC; right, MyLC; *n* = 10 experiments, respectively, of the sort shown in A). 5 µg of protein extract was used for the comparative MyHC quantification, and 20 µg of the myosin extract was used for MyLC quantification (arrows). (C) Comparison of fractional contribution of the MyHC (left) and MyLC (right) isoforms in WT and R6/2 interosseus. Because results for male and female mice were almost identical, they were pooled for the graphics. (D) Western blots of RyR1 from WT and R6/2 interosseus, and for each lane the corresponding total protein stain. (E) RyR1 (relative to stained protein) shows no significant difference between WT (0.021 ± 0.002; *n* = 12) and R6/2 (0.0272 ± 0.002; *n* = 12) interosseus. Data are means ± SEM. \*, P \< 0.05; \*\*\*, P \< 0.001.](JGP_201411255_Fig11){#fig11}

Finally, to check whether the dramatic decrease in Ca^2+^ release activity that we found results from a lower density of release channels, we quantified RyR1 protein expression by Western blotting using specific antibodies. [Fig. 11 D](#fig11){ref-type="fig"} shows representative blots (top) and [Fig. 11 E](#fig11){ref-type="fig"} shows the evaluation of all measurements as the RyR1 stain normalized to the total protein stain. The differences between WT and R6/2 interosseus were not significant. These results, therefore, indicate that the decrease in Ca^2+^ release is not caused by a reduced RyR1 expression.

DISCUSSION
==========

Calcium pathology in HD and skeletal muscle effects
---------------------------------------------------

htt, which in its mutant form (mhtt) is the cause of the neurodegenerative pathology of HD, is widely expressed in neuronal cells but is equally abundant in other tissues ([@bib100]; [@bib95]; [@bib114]; [@bib54]; [@bib88]). Several studies indicated that abnormal neuronal Ca^2+^ signaling plays a critical role in promoting neuronal death in HD ([@bib16]; [@bib7]; [@bib108], [@bib109]; [@bib96]; [@bib5], [@bib6]; [@bib33]). Recently, the muscle relaxant dantrolene and other inhibitors of RyRs have been shown to reduce neuronal cell death ([@bib19]; [@bib103]). Because skeletal muscle is one of the peripheral tissues affected in HD ([@bib95]; [@bib69]; [@bib21]; [@bib88]) and RyR1 plays a pivotal role in this tissue, our attention focused on the voltage-controlled RyR1-based Ca^2+^ signaling in skeletal muscle of the mouse HD model R6/2 ([@bib55]). Ca^2+^ signaling in skeletal muscle can be disturbed by alterations in (a) Ca^2+^ influx through plasma membrane channels, (b) release of Ca^2+^ from intracellular stores, (c) the membrane potential signal that controls these fluxes, and (d) Ca^2+^ removal from the cytoplasm. In this study, we demonstrated changes in all four aspects of muscular Ca^2+^ signaling.

Fiber morphology, myosin isoforms, and membrane excitation
----------------------------------------------------------

[@bib78] investigated morphology and fiber membrane properties of R6/2 skeletal muscle. Electrophysiology was performed by this group on flexor digitorum brevis (FDB) muscle fibers because of their short-cable properties. We used the interosseus, a muscle that exhibits equally short fibers and, unlike FDB, consists largely of a single fiber type (fast oxidative, type IIA; [@bib34], and this study). In agreement with the results of [@bib78] and [@bib89] from FDB and quadriceps of R6/2 mice, the mean diameter of a large number of evaluated interosseus fibers was 21% smaller compared with WT. According to previous investigations, the change in muscle bulk in R6/2 mice results from a uniform fiber shrinkage without any evidence of myopathy ([@bib89]) except for certain abnormalities in the neuromuscular junctions, possibly suggesting altered trophic interaction with the motor neurons ([@bib78]). One hypothesis to explain alterations in HD muscle was a transition from fast to slower fiber-type characteristics ([@bib78]; [@bib99]). Slow-twitch fibers are thinner and release a third to a fourth of the amount of Ca^2+^ per AP than fast fibers and show a lower capacity to store Ca^2+^ ([@bib3], [@bib4]; [@bib113]; [@bib67]). Typical characteristics of a change in fiber type are alterations in the MyHCs ([@bib73]; [@bib98]; [@bib112]; [@bib34]; [@bib90]). In the interosseus muscle, we detected no alteration in the relative amount of MyHC isoforms. Therefore, the functional changes that we observed in this muscle do not seem to result from a prototypical fast to slow transformation in fiber type. This is in line with recent findings indicating that fiber properties including Ca^2+^ signaling may change independently of MyHC content ([@bib12]; [@bib13]; [@bib26]). Small but significant changes were seen by us in the light chain pattern of myosin ([Fig. 11 C](#fig11){ref-type="fig"}) and might go in parallel with adaptations in the excitation--contraction coupling (ECC) apparatus. Although we could not detect any differences in the amount of RyR1 ([Fig. 11 E](#fig11){ref-type="fig"}) between WT and R6/2 interosseus, RyR1-associated proteins may be affected and deserve attention in future studies.

In FDB fibers of symptomatic R6/2 mice, [@bib78] measured lower resting potentials than in WT (by ∼10 mV), a higher input resistance, and a threefold larger membrane time constant. Moreover, a substantially higher incidence of anode-break APs was seen in R6/2 fibers, which may indicate a higher degree of inactivation of the voltage-dependent sodium channels caused by the partial depolarization. In general agreement with these findings, we observed an increase in rise time and time-to-peak of 71 and 42%, respectively, and a 48% increase in the half-time of decay of optically recorded APs. The fact that APs could be completely suppressed in our experiments by 100 nM TTX argues against a significant exchange of Na~V~1.4 for Na~V~1.5, i.e., a variant with low TTX sensitivity ([@bib123]), as suggested by [@bib78]. In any case, as discussed below, our results rule out that the observed changes in fiber excitation are sufficient to explain the differences in Ca^2+^ signaling reported here.

Changes in Ca^2+^ removal
-------------------------

The slower kinetics of Ca^2+^ relaxation in R6/2 fibers at the end of a single AP or a train of APs indicate changes in the mechanisms that clear the myoplasm of released Ca^2+^. We simulated Ca^2+^ binding and clearance using a kinetic model (see Materials and methods) in which the parameters of the fast and slow sites of troponin C were fixed to values obtained from the literature ([@bib79]; [@bib3]), whereas a saturating and a nonsaturating slow transport mechanism were adjusted to fit the measured relaxation time course. In addition, we tried seven other variants of the model to test the sensitivity of the result to changes in the assumptions. These alternative analyses included (a) a decrease in the off-rate constant of the fast sites of troponin C by a factor of 10 to a value originally reported by [@bib79], (b) the use of only a single freely adjustable slow binding component (i.e., omission of the fixed set of slow Ca^2+^-Mg^2+^ sites of troponin C), and (c) an increase in the K~D~ value of fura-2 by a factor of 3 (by lowering the on-rate constant) to account for possible effects of the protein environment on the indicator dye ([@bib46]). All analyses produced qualitatively similar results, leading to a significant decrease in the extent of slow Ca^2+^ removal (as shown in [Fig. 4](#fig4){ref-type="fig"}). A likely candidate to explain these changes is the SERCA calcium pump, the ATP-driven enzyme that is responsible for SR reloading after Ca^2+^ release. Myoplasmic buffers (like parvalbumin) or Ca^2+^ uptake by mitochondria ([@bib122]; [@bib124]) could also contribute to the difference in Ca^2+^ removal. Parvalbumin is absent in type IIA fibers of mice ([@bib35]), but mitochondria are highly abundant and defects in mitochondrial function have been described for R6/2 muscle ([@bib38]; see below).

Changes in Ca^2+^ release and Ca^2+^ inward current
---------------------------------------------------

A significant reduction in muscle strength measured with a handheld dynamometer has been reported in people with HD. HD patients presented about half the isometric strength of healthy matched control subjects when different muscle groups were tested ([@bib11]). A possible reason is dysfunctional Ca^2+^ release. Because Ca^2+^ binding and transport is quantified in the Ca^2+^ removal analysis, summing the time derivatives of all Ca^2+^ components provides a straightforward way to estimate the total Ca^2+^ flux (input flux) into the myoplasm ([@bib60]; [@bib111]; [@bib92]; [@bib118]). This flux is essentially identical to Ca^2+^ release from the SR ([@bib118]). The mean amplitude of Ca^2+^ input flux of intact R6/2 fibers stimulated by APs was found to be only 39% of that in WT fibers. To exclude that the strong difference in Ca^2+^ removal activity ([Fig. 4 B](#fig4){ref-type="fig"}) determined in our model analysis simply results from smaller flux rates, we used the mean WT Ca^2+^ release flux, scaled down by the same factor, as input to the same model (same parameters) to simulate artificial fluorescence ratio traces. The analysis of the simulated ratio led to identical overall slow removal activity in contrast to the result of [Fig. 4 B](#fig4){ref-type="fig"}.

The voltage-clamp technique allowed for the study in further detail of the alterations in Ca^2+^ release and, in addition, permitted the assessment of properties of the voltage-dependent Ca^2+^ entry from the extracellular space ([@bib118]). Voltage-clamp experiments on nondialyzed R6/2 fibers (i.e., with minimally disturbed intracellular space) showed similar results as those found in AP-stimulated fibers: The maximum rate of rise and rate of decay of the fluorescence ratio signal were significantly smaller than in WT fibers, pointing to a smaller peak Ca^2+^ release flux and reduced Ca^2+^ removal activity ([Fig. 6](#fig6){ref-type="fig"}). In agreement with these findings, dialyzed R6/2 fibers also showed a significantly reduced Ca^2+^ release flux (to 41%; [Table 2](#tbl2){ref-type="table"}). The correction for putative Ca^2+^ depletion ([@bib91]; [@bib39]) indicated a significantly smaller peak SR Ca^2+^ permeability than WT fibers (to 59%). On average, the Ca^2+^ content of the SR, simultaneously estimated with this method, was reduced to 66% in R6/2 compared with WT fibers, with a relatively large fiber-to-fiber variance. Therefore, the decreased Ca^2+^ release flux in R6/2 fibers may originate from a combination of smaller Ca^2+^ permeability and (to a lesser degree) lower SR Ca^2+^ load, perhaps as a consequence of the reduced uptake activity (see [Fig. 4](#fig4){ref-type="fig"}). A less effective reuptake may also explain the stronger decrease in peak release seen in repetitively stimulated R6/2 muscle fibers ([Fig. 5 B](#fig5){ref-type="fig"}).

Voltage-activated Ca^2+^ inward current is a further potential source of cytoplasmic Ca^2+^, and neuronal Ca^2+^ channels have been reported to be targets of htt ([@bib62]). In skeletal muscle, L-type Ca^2+^ channels serve as voltage sensors for RyR1 activation. Their Ca^2+^ inward current contributes much less than RyR1-mediated Ca^2+^ release to the myoplasmic Ca^2+^ elevation ([@bib118]). Although maximal L-type Ca^2+^ current was reduced in R6/2 fibers, it was actually larger than in WT, at voltages up to 0 mV, caused by its more negative threshold of activation ([Fig. 9 A](#fig9){ref-type="fig"}). Because the steady-state characteristics of voltage-dependent inactivation were unchanged ([Fig. 10 A](#fig10){ref-type="fig"}), an increase in window Ca^2+^ inward current and therefore an increase in a small but persistent Ca^2+^ flow from the extracellular space into fibers, depending on the degree of depolarization at rest (see inset in [Fig. 10 A](#fig10){ref-type="fig"}), is predicted. This effect might enhance any preexisting depolarization and cause cellular Ca^2+^ overload in partially depolarized fibers.

Potential mechanisms explaining mhtt effects on muscle ECC
----------------------------------------------------------

Because of the highly disabling impact of muscle weakness and atrophy resulting from disuse, aging, or disease, the mechanisms of such weakness are the targets of intense research ([@bib45]; [@bib57]; [@bib122]; [@bib85]; [@bib81]). Functional changes in addition to atrophy often lead to stronger weakness than expected from the change in muscle mass alone ([@bib56]). Specifically, ECC, the most prominent process in muscle that affects Ca^2+^ homeostasis, is changed in various pathologies ([@bib84]; [@bib34]; [@bib43]; [@bib110]; [@bib1]; [@bib126]; [@bib27]; [@bib56]). Our results from R6/2 mice indicate that this is also true for skeletal muscle in HD.

Toxic poly-Q--containing proteolytic peptides of mhtt that interact with functional proteins are the basis of HD pathology ([@bib83]; [@bib94]; [@bib115]; [@bib44]). The scheme in [Fig. 12](#fig12){ref-type="fig"} provides a working hypothesis that combines our findings with the results of previous studies, demonstrating the effects of mhtt on cellular energetics and Ca^2+^ regulation ([@bib2]; [@bib53]; [@bib70]; [@bib20]; [@bib36], [@bib37]; [@bib87]; [@bib38]; [@bib51]; [@bib117]; [@bib9]; [@bib116]; [@bib19]; [@bib103]).

![Hypothetical mechanism of poly-Q toxicity in skeletal muscle ECC. In skeletal muscle, the depolarization of the transverse tubular system (TT) is sensed by the DHPR (Ca~V~1.1) and causes the release of Ca^2+^ from the terminal cisternae of the SR via RyRs (RyR1). The released Ca^2+^ ions initiate contraction by binding to troponin C. Ca^2+^ is also bound to other cytoplasmic sites (summarized as "buffers," including the indicator dye in the experimental setting). In parallel, Ca^2+^ is pumped back into the lumen of the SR by transport ATPases (SERCA) and is taken up by mitochondria. The scheme combines several documented mechanisms (see Discussion for references) that could explain the reduced Ca^2+^ release and Ca^2+^ removal in R6/2 muscle fibers identified in this study: Mitochondria, challenged by mhtt, release ROS (1) causing thiol oxidation of SR proteins. SERCA is inhibited (2), and RyR1 is activated (3) by ROS-induced oxidation. The resulting rise in the cytoplasmic Ca^2+^ concentration causes mitochondrial Ca^2+^ overload and is part of a feed-forward cycle (labeled in blue) that further enhances SR Ca^2+^ leak. Chronically elevated cytoplasmic Ca^2+^ concentration eventually uncouples TT and SR as a result of calpain-mediated hydrolysis of junctophilin (5). Uptake into mitochondria will cease (4) when the mitochondrial membrane depolarizes in response to Ca^2+^ overload. In the scheme, the continuous red arrows mark mechanisms that reduce Ca^2+^ removal from the cytoplasm, whereas the dashed red arrow marks a reduction in Ca^2+^ release that would counteract depletion of the SR. In addition to its effect on mitochondria, mhtt may also modulate RyR1 directly.](JGP_201411255_Fig12){#fig12}

There is evidence that mhtt affects mitochondrial function early during disease development ([@bib2]; [@bib70]; [@bib61]; [@bib87]; [@bib21], [@bib22]; [@bib38]; [@bib117]; [@bib9]; [@bib18]; [@bib23]; [@bib116]; [@bib63]). Mitochondria are in close contact to the SR, generate ATP for SR Ca^2+^ transport, and may even directly contribute to the rapid Ca^2+^ sequestration during ECC ([@bib8]; [@bib122]; [@bib124]; [@bib30]), probably involving the recently identified mitochondrial calcium uniporter ([@bib25]; [@bib71]). Therefore, mitochondrial impairment will inevitably affect Ca^2+^ signaling. One likely mechanism involves excess production of reactive redox radicals ([@bib102]; [@bib10]; [@bib30]; [@bib121]) that can modify thiol residues in RyR1 (activation) and the SERCA calcium pump (inhibition) ([@bib32]; [@bib66]; [@bib120]; [@bib102]). Uncompensated Ca^2+^ leak, mediated by oxidized RyR1 ([@bib103]), would lead to partial SR unloading and to a destructive feed-forward cycle ([Fig. 12](#fig12){ref-type="fig"}, blue arrows), as has been proposed for muscle expressing overactive mutant RyR1 causing malignant hyperthermia ([@bib29]). In this context, it is interesting that weight loss in spite of increased caloric intake has been observed in HD and has been attributed to an early hypermetabolic state of peripheral body tissue ([@bib64]). Mitochondrial Ca^2+^ overload resulting from the rise in cytoplasmic Ca^2+^ concentration would initially enhance the cycle and finally lead to the opening of the mitochondrial permeability transition pore, resulting in the collapse of the mitochondrial membrane potential, the major driving force for mitochondrial Ca^2+^ uptake ([@bib10]; [@bib76]). Chronically increased myoplasmic Ca^2+^ concentration is known to uncouple the transverse tubules ([Fig. 12](#fig12){ref-type="fig"}, TT) from the SR by hydrolysis of the connecting protein junctophilin, probably by Ca^2+^-dependent proteases (calpains; see [@bib68]), resulting in the inhibition of voltage-activated Ca^2+^ release (red dashed arrow), as found in our experiments.

Instead of being caused by a primary dysfunction of the energy metabolism, the events outlined in [Fig. 12](#fig12){ref-type="fig"} could also be initiated by a direct effect of mhtt on the Ca^2+^ release units. A specific interaction between the htt-associated protein 1 and both inositol-3-phosphate receptors and RyR has been reported for the brain ([@bib119]; Lindenberg, K.S., A. Davranche, F. Klein, A.V. Thomas, C. Lill, T. Lenk, L.R. Orlando, J. Kama, A.B. Young, G.B. Landwehrmeyer, and Y. Trottier. 2010. Sixth European Huntington's Disease Network Plenary Meeting. Abstr. A20). Similarly as reported for aged fast muscle ([@bib24]; [@bib86]; but see [@bib77]), a simple reduction of cellular RyR1 content does not seem to be the cause of the strongly suppressed Ca^2+^ release that we found ([Fig. 11 E](#fig11){ref-type="fig"}). Measurements on isolated Ca^2+^ release channels would be important to determine whether mhtt has a direct functional effect on RyR1.

In conclusion, the results presented here provide strong evidence for severely disturbed Ca^2+^ homeostasis in R6/2 skeletal muscle. Ca^2+^ entry, Ca^2+^ release, and Ca^2+^ removal were found to be reduced. Failure in ECC may, therefore, be a major cause for muscle weakness in HD, supporting the hypothesis that RyR1 function is affected. We suspect that these changes are interlinked with the reported energetic deficits caused by mhtt. Further studies are needed to pinpoint the specific primary sites of action that lead to the observed alterations in muscular Ca^2+^ signaling.
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